GlassScriptPhysician profile
Hong Tjoa
NPI 1093816233
$3,550.73
in general payments reported to CMS, 2019-2025
22 companies · $35.49 in 2025
The $35.49 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $609 · 2020: $528 · 2021: $1,061 · 2022: $977 · 2023: $341 · 2025: $35.49.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $376.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $376.15 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $665.77 | 2019-2023 | Leqvio |
| Janssen Pharmaceuticals, INC | $652.40 | 2019-2022 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $497.53 | 2019-2025 | Lifevest |
| Urovant Sciences INC | $267.14 | 2021-2022 | |
| E.R. Squibb & Sons, L.L.C. | $261.72 | 2019-2023 | Eliquis |
| Pfizer INC. | $240.43 | 2019-2023 | |
| Sumitomo Pharma America, INC. | $164.75 | 2023 | Gemtesa |
| Boehringer Ingelheim Pharmaceuticals, INC. | $157.60 | 2019-2022 | |
| Sanofi-Aventis U.S. LLC | $113.55 | 2021-2023 | |
| Merck Sharp & Dohme LLC | $103.76 | 2021-2023 | Verquvo, Belsomra |
| Astrazeneca Pharmaceuticals LP | $87.47 | 2019-2022 | |
| Esperion Therapeutics, INC. | $73.36 | 2021 | |
| Boston Scientific Corporation | $53.48 | 2020-2022 | |
| Ambu INC. | $43.94 | 2022 | |
| Amgen INC. | $34.20 | 2019 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bardy Diagnostics, INC. | $27.00 | 2020 | |
| Kowa Pharmaceuticals America, INC. | $25.58 | 2022 | |
| Abbott Laboratories | $23.94 | 2021 | |
| Ge Healthcare | $16.18 | 2019 | |
| Aegerion Pharmaceuticals, INC. | $15.43 | 2019 | |
| Axonics, INC. | $14.16 | 2021 | |
| Kci USA, INC. | $11.34 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Hong Tjoa listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.